- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/13 - Tumour cells, irrespective of tissue of origin
Patent holdings for IPC class A61K 35/13
Total number of patents in this class: 341
10-year publication summary
|
28
|
33
|
46
|
44
|
43
|
45
|
18
|
22
|
19
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Thomas Jefferson University | 548 |
13 |
| Iovance Biotherapeutics, Inc. | 366 |
11 |
| The Regents of the University of California | 20574 |
9 |
| The Board of Trustees of the Leland Stanford Junior University | 6600 |
5 |
| Board of Regents, The University of Texas System | 6050 |
5 |
| The Johns Hopkins University | 5825 |
5 |
| Mayo Foundation for Medical Education and Research | 3355 |
5 |
| Gradalis, Inc. | 50 |
5 |
| Trustees of Tufts College | 948 |
5 |
| Imvax, Inc. | 11 |
5 |
| UNM Rainforest Innovations | 472 |
5 |
| Memorial Sloan-Kettering Cancer Center | 2006 |
4 |
| Ohio State Innovation Foundation | 2320 |
4 |
| Pastoral Greenhouse Gas Research Ltd | 22 |
4 |
| Pulse Biosciences, Inc. | 178 |
4 |
| SOTIO a.s. | 24 |
4 |
| University of Massachusetts | 2298 |
4 |
| University of Miami | 857 |
4 |
| Medical Corporation Ichikawa Clinic | 4 |
4 |
| Novartis AG | 10327 |
3 |
| Other owners | 233 |